Cite

1. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, et al. on behalf of the 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014. 13:917-30 DOI: 10.1016/j.autrev.2014.05.00110.1016/j.autrev.2014.05.001Open DOISearch in Google Scholar

2. An GD, Lim HH, Han JY. Laboratory Diagnosis of Antiphospholipid Syndrome. Clin Exp Thromb Hemost. 2017.3(1):2-7.10.14345/ceth.17002Search in Google Scholar

3. Uthman I, Khamashta M. Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum.2006. 1: 360–367 DOI: 10.1016/j.semarthrit.2006.01.00110.1016/j.semarthrit.2006.01.001Open DOISearch in Google Scholar

4. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002. 346(10):752–63. DOI: 10.1056/NEJMra00297410.1056/NEJMra002974Search in Google Scholar

5. Caraiola S, Jurcuț C, Dima A, Băicuș C, Băicuș A. Antiphosphatidylethanolamine Antibodies and Deep Vein Thrombosis in Lupus Patients with Antiphospholipid Syndrome. Rev Romana Med Lab. 2018;26(2):243-50 DOI: 10.2478/rrlm-2018-000910.2478/rrlm-2018-0009Open DOISearch in Google Scholar

6. Gavriş C, Anghel M, Rădoi M, Gheorghiţă E, Duca L, Pamfil G, et al. Risk of recurrent thrombosis related to antiphospholipid antibodies, soluble CD40L and P selectin serum levels in patients with antiphospholipid syndrome secondary to systemic lupus eritematosus. Rev Romana Med Lab. 2010;18(3):23-30Search in Google Scholar

7. Falanga A, Marchetti M, Russo L. The mechanisms of cancer-associated thrombosis. Thromb Res. 2015. 135(Suppl 1):S8-S11 DOI: 10.1016/S0049-3848(15)50432-510.1016/S0049-3848(15)50432-5Open DOISearch in Google Scholar

8. Passamonti F, Caramazza D, Mora B, Casalone R, Maffioli M. It is time to change thrombosis risk assessment for PV and ET? Best Pract Res Clin Haematol. 2014; 27(2):121-127 DOI: 10.1016/j.beha.2014.07.00510.1016/j.beha.2014.07.00525189723Search in Google Scholar

9. Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. BLOOD. 2017, 129(25):3285-3293.10.1182/blood-2017-03-74230428483766Search in Google Scholar

10. Ahmed TS, Tewari P, Kaur J, Rizvi S, Nafsi T. Recurrence of Pulmonary Embolism While on Rivaroxaban: Treatment Failure. Chest Journal. 2016. 149(4):A05-0510.1016/j.chest.2016.02.527Search in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology